View this email in your browser<http://us11.campaign-archive2.com/?e=4aad33fd68&u=f8609630ae206654824f897b6&id=a9a64533f7>


[STAT]<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=aada225ca6&e=4aad33fd68>

Tuesday, June 13, 2017


[Cancer Briefing]


Sponsored by
 [https://gallery.mailchimp.com/f8609630ae206654824f897b6/images/a1922497-1cdc-4fdc-80f2-4219bb2ae5ee.png] <http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=2a0c7f97fc&e=4aad33fd68>



Here's the latest from STAT on research discoveries, drug development, treatment costs, and patient care, along with occasional opinion pieces. For more, visit statnews.com<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=afcfec2e28&e=4aad33fd68> and follow us on Facebook<http://statnews.us11.list-manage1.com/track/click?u=f8609630ae206654824f897b6&id=98b9d1c4d6&e=4aad33fd68> and Twitter<http://statnews.us11.list-manage1.com/track/click?u=f8609630ae206654824f897b6&id=7cb9a59c94&e=4aad33fd68>.


STAT Plus: Personalized cancer therapies show great promise. The hitch? Manufacturing them efficiently<http://statnews.us11.list-manage2.com/track/click?u=f8609630ae206654824f897b6&id=48c1658379&e=4aad33fd68>
By Meghana Keshavan

[5704559a-8978-4b90-8665-199cd70fbbd3.png]<http://statnews.us11.list-manage1.com/track/click?u=f8609630ae206654824f897b6&id=5c8054fba2&e=4aad33fd68>[6c991793-efa4-4905-ae53-0070e6ce14b6.png]<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=f148ff607a&e=4aad33fd68>


[https://www.statnews.com/wp-content/uploads/2016/12/kite2-1024x576.jpg]

Kite Pharma

It’s been a good month for companies developing the experimental immunotherapies known as CAR-T, as several released data showing strong results in patients with blood cancers.  Now, though, they face a new challenge: Proving they can actually manufacture<http://statnews.us11.list-manage2.com/track/click?u=f8609630ae206654824f897b6&id=1c77eaef3b&e=4aad33fd68> the highly personalized treatments quickly and efficiently — and get them to cancer patients across the country.

And hidden in some of the positive data are hints that such turnarounds will be tough.
Read More<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=a9f154fb8c&e=4aad33fd68>



Saying Los Angeles lacks a great cancer center, Soon-Shiong plans to open one<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=274f509755&e=4aad33fd68>
By Rebecca Robbins

[5704559a-8978-4b90-8665-199cd70fbbd3.png]<http://statnews.us11.list-manage1.com/track/click?u=f8609630ae206654824f897b6&id=9a60c22273&e=4aad33fd68>[6c991793-efa4-4905-ae53-0070e6ce14b6.png]<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=3067583f70&e=4aad33fd68>


[https://www.statnews.com/wp-content/uploads/2016/11/GettyImages-618377722-1024x576.jpg]

Darren McCollester/Getty Images

Dr. Patrick Soon-Shiong, the peripatetic billionaire out to reinvent health care, is striking out in yet another new direction: Opening what he’s billing as a new world-class cancer center in Los Angeles.

Soon-Shiong, who made his fortune developing a cancer drug, already runs companies that sell health care software, perform genetic sequencing, and work on experimental cancer therapies aimed at boosting the immune system. He was just named to a federal commission advising on health IT. And he’s steering a ‘moonshot’ initiative<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=2da79626a1&e=4aad33fd68> that he boasts is moving toward curing cancer by 2020.
Read More<http://statnews.us11.list-manage1.com/track/click?u=f8609630ae206654824f897b6&id=c344b4824c&e=4aad33fd68>



STAT Plus: Identifying another of cancer’s wily tricks: Masking pain so tumors can grow unnoticed<http://statnews.us11.list-manage2.com/track/click?u=f8609630ae206654824f897b6&id=d54a4f9f1f&e=4aad33fd68>
By Meghana Keshavan

[5704559a-8978-4b90-8665-199cd70fbbd3.png]<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=948b323c64&e=4aad33fd68>[6c991793-efa4-4905-ae53-0070e6ce14b6.png]<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=dee4bf1ef8&e=4aad33fd68>


[https://www.statnews.com/wp-content/uploads/2017/06/FINAL-PD-L1-1024x576.jpg]

Hyacinth Empinado/STAT

Key insight: PD-L1, a molecular target of cancer immunotherapy, is so closely tied to pain in animal experiments, scientists think it may mean the more pain is felt, the better the treatment is working.

Pain exists for a reason: It alerts us that something’s gone awry in our bodies. Now, a new study suggests that some cancers might block our ability to sense the pain that radiates from a tumor —allowing it to continue growing, surreptitiously.
Read More<http://statnews.us11.list-manage1.com/track/click?u=f8609630ae206654824f897b6&id=662be7f7c7&e=4aad33fd68>




Sponsor content by The Value Collaborative

How to create a reimbursement system as innovative as the medicines

Biopharmaceutical science is advancing faster than ever before, and we need to make sure we have a payment and reimbursement system that is as innovative as the medicines produced by our companies. In this era of rapidly changing, personalized medicine, the private market is best positioned to evolve our health care system in a productive direction for patients. Read more<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=abc1d406d7&e=4aad33fd68>.







New frontier in cancer care: Turning blood into living drugs<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=89e5f57597&e=4aad33fd68>
By Associated Press

[5704559a-8978-4b90-8665-199cd70fbbd3.png]<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=f4979f3f8a&e=4aad33fd68>[6c991793-efa4-4905-ae53-0070e6ce14b6.png]<http://statnews.us11.list-manage1.com/track/click?u=f8609630ae206654824f897b6&id=59439fb907&e=4aad33fd68>


[https://www.statnews.com/wp-content/uploads/2017/06/AP17102599696606-1024x576.jpg]

Elaine Thompson/AP

SEATTLE — Ken Shefveland’s body was swollen with cancer, treatment after treatment failing until doctors gambled on a radical approach: They removed some of his immune cells, engineered them into cancer assassins and unleashed them into his bloodstream.

Immune therapy is the hottest trend in cancer care and this is its next frontier — creating “living drugs” that grow inside the body into an army that seeks and destroys tumors.
Read More<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=a7bfcbc9f9&e=4aad33fd68>



Study finds pregnancy seems safe for breast cancer survivors<http://statnews.us11.list-manage1.com/track/click?u=f8609630ae206654824f897b6&id=89cf17741d&e=4aad33fd68>
By Associated Press

[5704559a-8978-4b90-8665-199cd70fbbd3.png]<http://statnews.us11.list-manage1.com/track/click?u=f8609630ae206654824f897b6&id=cfb006a35f&e=4aad33fd68>[6c991793-efa4-4905-ae53-0070e6ce14b6.png]<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=94470f4053&e=4aad33fd68>


[https://www.statnews.com/wp-content/uploads/2017/06/AP17152723217527-1024x576.jpg]

Dana J. Palmer via AP

CHICAGO — A study gives reassuring news for breast cancer survivors who want to have children. Those who later became pregnant were no more likely to have their cancer come back than those who did not have a baby.

It’s a big issue — the average age of moms has been rising in the United States, and more women are being diagnosed with breast cancer in their childbearing years. About 11 percent of new breast cancer cases in the U.S. are in women under 45.
Read More<http://statnews.us11.list-manage1.com/track/click?u=f8609630ae206654824f897b6&id=5fcfd0ab7c&e=4aad33fd68>



Financial counselors help patients navigate costly care<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=a6e90b8547&e=4aad33fd68>
By Associated Press

[5704559a-8978-4b90-8665-199cd70fbbd3.png]<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=8c6e732259&e=4aad33fd68>[6c991793-efa4-4905-ae53-0070e6ce14b6.png]<http://statnews.us11.list-manage1.com/track/click?u=f8609630ae206654824f897b6&id=bd1e024145&e=4aad33fd68>


[https://www.statnews.com/wp-content/uploads/2017/06/AP17158550622060-1024x576.jpg]

Darron Cummings/AP

INDIANAPOLIS — The financial counselor will see you now.

Many people hit with a terrifying medical diagnosis like cancer also have to deal with another worry: whether the care will bankrupt them.
Read More<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=95ef69929f&e=4aad33fd68>





[Facebook]<http://statnews.us11.list-manage2.com/track/click?u=f8609630ae206654824f897b6&id=65abfb79f7&e=4aad33fd68>

[Twitter]<http://statnews.us11.list-manage.com/track/click?u=f8609630ae206654824f897b6&id=b4f72f5ecc&e=4aad33fd68>

[STAT]<http://statnews.us11.list-manage1.com/track/click?u=f8609630ae206654824f897b6&id=7a104ccc62&e=4aad33fd68>